Priyanka Sinoliya, Ravi Ranjan Kumar Niraj, Vinay Sharma
{"title":"破解密码:纳米信息学如何制造智能纳米武器以战胜多重耐药性(MDR)。","authors":"Priyanka Sinoliya, Ravi Ranjan Kumar Niraj, Vinay Sharma","doi":"10.2174/0122117385383102250818052847","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Multiple Drug Resistance (MDR) is one of the prime concerns globally in the health sector. The emergence and proliferation of ESKAPE pathogens, along with drug resistance in cancer cells, represent a significant challenge to public health, emphasizing the need for novel therapeutics, improved infection control practices, and ongoing research to understand and combat antibiotic resistance. Addressing multiple drug resistance involves several modern therapeutic strategies, such as phage therapy, immunotherapy, combinatorial therapy, and more. Advanced diagnostic tools, effective control measures, and stringent regulatory and policy initiatives raising public awareness are also crucial.</p><p><strong>Methods: </strong>This study scouted computational approaches, focusing on their application in nanotechnology and nano-drug systems in clinical settings. A systematic approach was employed to gather, screen, and critically analyze the relevant literature for this review.</p><p><strong>Results: </strong>This study found that various tools and databases are evolving for reconnaissance in the field of nano-informatics, which will lead to research and development.</p><p><strong>Discussion: </strong>This study highlights the rapid advancement of nano-informatics tools and databases, which are crucial for advancing computational approaches in nanomedicine and therapeutic research. These emerging resources support predictive analysis and integration with biological datasets, though challenges remain in data standardization, accessibility, and interoperability across platforms.</p><p><strong>Conclusion: </strong>To mitigate multiple drug resistance, researchers are exploring various approaches, and nano-informatics can provide new insight into dealing with it. This approach will advance the development of medical devices, drug design, and delivery systems.</p>","PeriodicalId":19774,"journal":{"name":"Pharmaceutical nanotechnology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cracking the Code: How Nano-Informatics is Crafting Intelligent Nano-Weapons to Outsmart Multiple Drug Resistance (MDR).\",\"authors\":\"Priyanka Sinoliya, Ravi Ranjan Kumar Niraj, Vinay Sharma\",\"doi\":\"10.2174/0122117385383102250818052847\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Multiple Drug Resistance (MDR) is one of the prime concerns globally in the health sector. The emergence and proliferation of ESKAPE pathogens, along with drug resistance in cancer cells, represent a significant challenge to public health, emphasizing the need for novel therapeutics, improved infection control practices, and ongoing research to understand and combat antibiotic resistance. Addressing multiple drug resistance involves several modern therapeutic strategies, such as phage therapy, immunotherapy, combinatorial therapy, and more. Advanced diagnostic tools, effective control measures, and stringent regulatory and policy initiatives raising public awareness are also crucial.</p><p><strong>Methods: </strong>This study scouted computational approaches, focusing on their application in nanotechnology and nano-drug systems in clinical settings. A systematic approach was employed to gather, screen, and critically analyze the relevant literature for this review.</p><p><strong>Results: </strong>This study found that various tools and databases are evolving for reconnaissance in the field of nano-informatics, which will lead to research and development.</p><p><strong>Discussion: </strong>This study highlights the rapid advancement of nano-informatics tools and databases, which are crucial for advancing computational approaches in nanomedicine and therapeutic research. These emerging resources support predictive analysis and integration with biological datasets, though challenges remain in data standardization, accessibility, and interoperability across platforms.</p><p><strong>Conclusion: </strong>To mitigate multiple drug resistance, researchers are exploring various approaches, and nano-informatics can provide new insight into dealing with it. This approach will advance the development of medical devices, drug design, and delivery systems.</p>\",\"PeriodicalId\":19774,\"journal\":{\"name\":\"Pharmaceutical nanotechnology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceutical nanotechnology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0122117385383102250818052847\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical nanotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0122117385383102250818052847","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
Cracking the Code: How Nano-Informatics is Crafting Intelligent Nano-Weapons to Outsmart Multiple Drug Resistance (MDR).
Introduction: Multiple Drug Resistance (MDR) is one of the prime concerns globally in the health sector. The emergence and proliferation of ESKAPE pathogens, along with drug resistance in cancer cells, represent a significant challenge to public health, emphasizing the need for novel therapeutics, improved infection control practices, and ongoing research to understand and combat antibiotic resistance. Addressing multiple drug resistance involves several modern therapeutic strategies, such as phage therapy, immunotherapy, combinatorial therapy, and more. Advanced diagnostic tools, effective control measures, and stringent regulatory and policy initiatives raising public awareness are also crucial.
Methods: This study scouted computational approaches, focusing on their application in nanotechnology and nano-drug systems in clinical settings. A systematic approach was employed to gather, screen, and critically analyze the relevant literature for this review.
Results: This study found that various tools and databases are evolving for reconnaissance in the field of nano-informatics, which will lead to research and development.
Discussion: This study highlights the rapid advancement of nano-informatics tools and databases, which are crucial for advancing computational approaches in nanomedicine and therapeutic research. These emerging resources support predictive analysis and integration with biological datasets, though challenges remain in data standardization, accessibility, and interoperability across platforms.
Conclusion: To mitigate multiple drug resistance, researchers are exploring various approaches, and nano-informatics can provide new insight into dealing with it. This approach will advance the development of medical devices, drug design, and delivery systems.
期刊介绍:
Pharmaceutical Nanotechnology publishes original manuscripts, full-length/mini reviews, thematic issues, rapid technical notes and commentaries that provide insights into the synthesis, characterisation and pharmaceutical (or diagnostic) application of materials at the nanoscale. The nanoscale is defined as a size range of below 1 µm. Scientific findings related to micro and macro systems with functionality residing within features defined at the nanoscale are also within the scope of the journal. Manuscripts detailing the synthesis, exhaustive characterisation, biological evaluation, clinical testing and/ or toxicological assessment of nanomaterials are of particular interest to the journal’s readership. Articles should be self contained, centred around a well founded hypothesis and should aim to showcase the pharmaceutical/ diagnostic implications of the nanotechnology approach. Manuscripts should aim, wherever possible, to demonstrate the in vivo impact of any nanotechnological intervention. As reducing a material to the nanoscale is capable of fundamentally altering the material’s properties, the journal’s readership is particularly interested in new characterisation techniques and the advanced properties that originate from this size reduction. Both bottom up and top down approaches to the realisation of nanomaterials lie within the scope of the journal.